Oops, Fake-Out

Merck published a journal containing reprinted or review articles that reported data favorable to the drug company, all without disclosing its sponsorship of the journal, says The Scientist. The journal, called the Australasian Journal of Bone and Joint Medicine, was published by a division of Elsevier, to which Merck paid an undisclosed sum, the article says. "To the jaundiced eye, [the journal] might be detected for what it is: marketing," Public Citizen's Peter Lurie says.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.